A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
RemeGen Co., Ltd.
RemeGen Co., Ltd.
TaiHao Medical Inc.
Maastricht University Medical Center
IRCCS San Raffaele
Centro di Riferimento Oncologico - Aviano
Sun Yat-sen University
KK Women's and Children's Hospital
ChineseAMS
Zhejiang Cancer Hospital
Peking Union Medical College Hospital
Zhejiang Cancer Hospital
King's College London
University of British Columbia
Women's College Hospital